These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2658896)

  • 41. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.
    Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT
    Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Carriers of Staphylococcus aureus as a source of nosocomial infections. Epidemiological and prophylactic aspects].
    Kolmos HJ
    Ugeskr Laeger; 1999 Mar; 161(11):1580-4. PubMed ID: 10202440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease.
    Martin JN; Perdreau-Remington F; Kartalija M; Pasi OG; Webb M; Gerberding JL; Chambers HF; Täuber MG; Lee BL
    J Infect Dis; 1999 Sep; 180(3):896-9. PubMed ID: 10438389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clonality of Staphylococcus aureus nasal carriage.
    Cespedes C; Said-Salim B; Miller M; Lo SH; Kreiswirth BN; Gordon RJ; Vavagiakis P; Klein RS; Lowy FD
    J Infect Dis; 2005 Feb; 191(3):444-52. PubMed ID: 15633104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New strategies for the use of mupirocin for the prevention of serious infection.
    Mehtar S
    J Hosp Infect; 1998 Sep; 40 Suppl B():S39-44. PubMed ID: 9777532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection.
    Wenzel RP; Perl TM
    J Hosp Infect; 1995 Sep; 31(1):13-24. PubMed ID: 7499817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nasal and skin colonization of Staphylococcus aureus in hemodialysis patients in Northeast of Iran.
    Ghazvini K; Hekmat R
    Iran J Kidney Dis; 2007 Jul; 1(1):21-4. PubMed ID: 19357439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis.
    Perl TM
    Surgery; 2003 Nov; 134(5 Suppl):S10-7. PubMed ID: 14647028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tackling the anterior nares and other sites of colonization: implications for the dermatologist.
    Del Rosso JQ; Elston DM
    Cutis; 2007 Jun; 79(6 Suppl):52-9. PubMed ID: 17649858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The nose: an underestimated source of Staphylococcus aureus causing wound infection.
    Casewell MW
    J Hosp Infect; 1998 Sep; 40 Suppl B():S3-11. PubMed ID: 9777528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staphylococcus aureus infections in dialysis patients: focus on prevention.
    Piraino B
    ASAIO J; 2000; 46(6):S13-7. PubMed ID: 11110288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nasal carriage of Staphylococcus aureus treated with topical mupirocin (pseudomonic acid) in a children's hospital.
    Frank U; Lenz W; Damrath E; Kappstein I; Daschner FD
    J Hosp Infect; 1989 Feb; 13(2):117-20. PubMed ID: 2567303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection and clinical relevance of Staphylococcus aureus nasal carriage: an update.
    Verhoeven PO; Gagnaire J; Botelho-Nevers E; Grattard F; Carricajo A; Lucht F; Pozzetto B; Berthelot P
    Expert Rev Anti Infect Ther; 2014 Jan; 12(1):75-89. PubMed ID: 24308709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis.
    Watanakunakorn C; Brandt J; Durkin P; Santore S; Bota B; Stahl CJ
    Am J Infect Control; 1992 Jun; 20(3):138-41. PubMed ID: 1636934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients.
    Boelaert JR; De Smedt RA; De Baere YA; Godard CA; Matthys EG; Schurgers ML; Daneels RF; Gordts BZ; Van Landuyt HW
    Nephrol Dial Transplant; 1989; 4(4):278-81. PubMed ID: 2502734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. S. aureus nasal carriage: importance and approaches.
    Piraino B
    Perit Dial Int; 1995; 15(8):301-2. PubMed ID: 8785225
    [No Abstract]   [Full Text] [Related]  

  • 57. Staphylococcus aureus septic arthritis in patients on hemodialysis treatment.
    Slaughter S; Dworkin RJ; Gilbert DN; Leggett JE; Jones S; Bryant R; Martin MA
    West J Med; 1995 Aug; 163(2):128-32. PubMed ID: 7571559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of Staphylococcal carriage.
    Goldblum SE; Ulrich JA; Goldman RS; Reed WP
    Am J Kidney Dis; 1982 Sep; 2(2):281-6. PubMed ID: 7124725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Staphylococcus aureus. The persistent pathogen (second of two parts).
    Sheagren JN
    N Engl J Med; 1984 May; 310(22):1437-42. PubMed ID: 6371536
    [No Abstract]   [Full Text] [Related]  

  • 60. Vascular access infection associated with methicillin-resistant Staphylococcus aureus nasal carriage in a hemodialysis patient.
    Takeda K; Nakamoto M; Yasunaga C; Nishihara G; Matsuo K; Urabe M; Goya T
    Nephron; 1997; 76(3):371-2. PubMed ID: 9226252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.